YOKNEAM, Israel, Oct. 4, 2012 /PRNewswire/ -- Syneron Medical Ltd.
(NASDAQ:ELOS), the leading global aesthetic device company,
announced today that it is highlighting several new products at the
IMCAS (International Master Course on Aging Skin) Asia meeting, which is taking place from
October 4-6, 2012 in Hong Kong. The highlighted new products
include a high-energy eTwo™ tabletop platform system, the Gentle
Pro-U Series of upgradeable aesthetic laser systems, and the elos
Plus™ next generation multi-platform system.
(Logo: http://photos.prnewswire.com/prnh/20120528/535447 )
The eTwo platform, with its Sublime™ and Sublative™
applications, is approved for dermatological procedures requiring
ablation and resurfacing in addition to non-invasive wrinkle
treatment. The high-energy version of the eTwo system enhances its
already effective skin rejuvenation treatments, which increase
collagen and elastin production for a brighter and smoother
complexion, with minimal dermal disruption across all skin colors
and skin tones. It supports Syneron's Sublative iD tips, which are
designed to maximize treatment options and results.
Louis P. Scafuri, Chief Executive
Officer of Syneron, commented, "The new high-energy eTwo system
improves upon the original by allowing for faster treatment times,
fewer treatment sessions, and enhanced patient results. It features
our unique Sublime and Sublative applications, which provide
comprehensive facial rejuvenation in a safe and effective treatment
for patients of all skin types. Since its launch earlier this year,
the eTwo platform has been well received by our customers because
of its exceptional patient satisfaction and favorable cost of
acquisition and ownership. We believe the new high-energy version
will continue to drive adoption of the eTwo platform in the
marketplace."
The Gentle Pro-U Series includes the GentleLase Pro-U long pulse
alexandrite laser for hair removal and the treatment of pigmented
and vascular lesions, and the GentleYag Pro-U long pulse Nd:YAG
laser for hair removal and the treatment of spider veins and
telangiectasia. It builds on the strong brand history of Gentle
family of aesthetic laser systems with ability to upgrade either
system from single to dual wavelength, providing an even more
diverse range of treatment capabilities.
elos Plus™ is a next generation multi-platform system featuring
Syneron's proprietary elos technology. It is customizable or
upgradable utilizing a full range of up to ten in-demand aesthetic
applicators, which also includes the Company's globally successful
Sublative™ and Sublime™ applications. It has an intuitive
fifteen-inch touch screen that offers unparalleled ease-of-use
through simple but powerful guided treatment modes for all
applications. The system is also equipped with the most popular
features from recent Syneron models such as the proprietary Active
Dermal Monitoring™, Intelligent Feedback System™ (IFS) and
Sublative iD™, making elos Plus™ an ideal choice for any aesthetic
practice.
Syneron's and Candela's products, including the high-energy eTwo
system, elos Plus™ system, and the Gentle Pro-U Series, will be
featured at adjoining booths #B02 and #C01 at the IMCAS Asia
meeting.
About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global
aesthetic device company with a comprehensive product portfolio and
a global distribution footprint. The Company's technology enables
physicians to provide advanced solutions for a broad range of
medical-aesthetic applications including body contouring, hair
removal, wrinkle reduction, rejuvenation of the skin's appearance
through the treatment of superficial benign vascular and pigmented
lesions, and the treatment of acne, leg veins and cellulite. The
Company sells its products under two distinct brands, Syneron and
Candela. Founded in 2000, the corporate, R&D, and manufacturing
headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and
manufacturing operations in the US. The Company markets, services
and supports its products in 90 countries. It has offices in
North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan,
and Hong Kong and distributors
worldwide.
SOURCE Syneron Medical Ltd.